HYPEROXALURIA

Clinical trials for HYPEROXALURIA explained in plain language.

Never miss a new study

Get alerted when new HYPEROXALURIA trials appear

Sign up with your email to follow new studies for HYPEROXALURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Could a phosphate drug also stop kidney stones?

Disease control Completed

This study tested whether Tenapanor, a drug approved for kidney disease, can reduce oxalate absorption from food and lower the risk of kidney stones. Eighteen healthy adults without a history of stones took the drug or a placebo, and their urine oxalate levels were compared. The …

Matched conditions: HYPEROXALURIA

Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control

Last updated Jun 27, 2026 09:02 UTC

HYPEROXALURIA

Get alerted when new HYPEROXALURIA trials appear

Could a phosphate drug also stop kidney stones?